Orrù, G.; Scano, A.; Fais, S.; Loddo, M.; Carta, M.G.; Steri, G.C.; Santus, S.; Cappai, R.; Ferrando, M.L.; Coghe, F.
Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification. Pathogens 2021, 10, 325.
https://doi.org/10.3390/pathogens10030325
AMA Style
Orrù G, Scano A, Fais S, Loddo M, Carta MG, Steri GC, Santus S, Cappai R, Ferrando ML, Coghe F.
Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification. Pathogens. 2021; 10(3):325.
https://doi.org/10.3390/pathogens10030325
Chicago/Turabian Style
Orrù, Germano, Alessandra Scano, Sara Fais, Miriam Loddo, Mauro Giovanni Carta, Giorgio Carlo Steri, Simonetta Santus, Riccardo Cappai, Maria Laura Ferrando, and Ferdinando Coghe.
2021. "Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification" Pathogens 10, no. 3: 325.
https://doi.org/10.3390/pathogens10030325
APA Style
Orrù, G., Scano, A., Fais, S., Loddo, M., Carta, M. G., Steri, G. C., Santus, S., Cappai, R., Ferrando, M. L., & Coghe, F.
(2021). Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification. Pathogens, 10(3), 325.
https://doi.org/10.3390/pathogens10030325
